DIGP - DigiPath, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.186
+0.001 (+0.54%)
At close: 3:50PM EDT
Stock chart is not supported by your current browser
Previous Close0.185
Open0.190
Bid0.000 x 0
Ask0.000 x 0
Day's Range0.185 - 0.205
52 Week Range0.150 - 0.590
Volume74,102
Avg. Volume103,825
Market Cap7.304M
Beta3.04
PE Ratio (TTM)N/A
EPS (TTM)-0.035
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • PR Newswire3 days ago

    Digipath Makes Progress with its Cannabis Testing Lab Joint Venture in Humboldt County, CA

    LAS VEGAS, May 17, 2018 /PRNewswire/ -- Digipath, Inc. (DIGP), a service-oriented independent testing laboratory and media firm focused on the developing cannabis market, is pleased to provide this update on its previously announced joint venture to operate a cannabis testing laboratory in Humboldt County, CA. The cannabis lab will be well positioned to service all Humboldt County growers as well as growers located in neighboring Mendocino County.  This is significant, as Santa Barbara, Mendocino, Monterey, and Calaveras Counties account for 74% of the 1,256 cultivation licenses issued so far in California, with Humboldt County alone representing 20% of this total.

  • PR Newswire4 days ago

    Digipath Posts Revenue and EBITDA Results for Fiscal Second Quarter 2018

    LAS VEGAS , May 15, 2018 /PRNewswire/ --  Digipath, Inc. (OTCQB: DIGP) ("DIGP" or the "Company"), a service oriented independent testing laboratory and media firm focused on the developing ...

  • PR Newswirelast month

    Digipath's Chief Science Officer's Research on Cannabis Cultivar Classification Featured in Cannabis Science and Technology Magazine

    LAS VEGAS, April 17, 2018 /PRNewswire/ -- Digipath, Inc. (DIGP), a service-oriented independent testing laboratory and media firm focused on the developing cannabis market, is pleased to announce that research by its Chief Science Officer, Dr. Cindy Orser, published in the peer-reviewed scientific journal Natural Products Chemistry & Research, has been featured in Cannabis Science and Technology Magazine's first issue released March 2018. Dr. Orser's research focuses on the methodical classification of cultivars of the Cannabis sativa plant through broad genotypic and chemotypic analysis that includes not only cannabinoids but also terpenoids. Dr. Orser's research has found that unique terpenoid chemoprofile patterns exist and can be assigned to specific cultivars.

  • PR Newswire3 months ago

    Digipath Posts Record Revenue and EBITDA Results for Fiscal First Quarter 2018

    Company to Hold Conference Call to Review Results LAS VEGAS , Feb. 12, 2018 /PRNewswire/ -- Digipath, Inc. (OTCQB: DIGP) ("DIGP" or the "Company"), a service oriented independent testing ...

  • PR Newswire4 months ago

    Digipath Labs Resumes Testing Operations Following Reinstatement of Nevada Licenses

    LAS VEGAS, Feb. 1, 2018 /PRNewswire/ -- Digipath, Inc. (DIGP), a service-oriented independent cannabis testing laboratory and media firm focused on the developing cannabis market, announced today that it has resumed cannabis testing operations following the reinstatement of the Medical Marijuana Registration Certificate and Marijuana Testing Facility License held by its wholly-owned subsidiary, Digipath Labs. This follows a full audit of the Company's lab facilities by the Nevada Department of Taxation, Marijuana Enforcement Division and the Department's approval of the Plan of Correction submitted by Digipath Labs. Digipath Labs also received its Clark County Business License allowing full operation in the county and the state.

  • PR Newswire4 months ago

    Digipath Hires Molecular Biologist|BioChemist Dr. Kimberly Ross, PhD, As Director of Quality Systems

    LAS VEGAS, Jan. 29, 2018 /PRNewswire/ -- Digipath, Inc. (DIGP), a service-oriented independent cannabis testing laboratory and media firm focused on the developing cannabis market, announced that it has hired Dr. Kimberly Ross, PhD, a seasoned molecular microbiologist and biochemist, as its Director of Quality Systems for its wholly owned subsidiary, Digipath Labs. Dr. Ross will lead the team responsible for implementing quality systems ensuring that all testing is conducted in compliance with Good Laboratory Practices, ISO-17205 standards and the regulations set by Nevada's Department of Taxation.  Dr. Ross will also work directly with Chief Science Officer, Dr. Cindy Orser, PhD, in overseeing the proper training of all new lab personnel. Dr. Ross brings to Digipath Labs experience as a Technical Director under the NELAC (National Environmental Laboratory Accreditation Program) Institute's rigorous accreditation program, where she was responsible for all aspects of data realization, client report generation, and laboratory operations within a compliant Quality Management System.

  • PR Newswire4 months ago

    Digipath To Submit a Plan of Correction to the State of Nevada's Department of Taxation, Marijuana Enforcement Division in Response to License Suspension

    LAS VEGAS , Jan. 22, 2018 /PRNewswire/ --  Digipath, Inc. (OTCQB: DIGP), a service-oriented independent cannabis testing laboratory and media firm focused on the developing cannabis market, announced that ...

  • PR Newswire4 months ago

    Digipath Labs Publishes Research on Application of Terpenoid Profiles in Cannabis Classification

    LAS VEGAS, Jan. 11, 2018 /PRNewswire/ -- Digipath, Inc. (DIGP) ("DIGP" or the "Company"), a service oriented independent cannabis testing laboratory and media firm focused on the developing cannabis market, today announced that Dr. Cindy Orser, Chief Science Officer at Digipath Labs, recently published original research on the application of terpenoid chemoprofiles for cannabis classification in the peer-reviewed journal, Natural Products Chemistry & Research. This research furthers Digipath's scientific analysis on the importance of terpenoid data for growers and consumers. Dr. Cindy Orser commented, "We propose that three terpenoid cluster assignments account for the diversity of drug-type cannabis strains currently being grown in Nevada.

  • PR Newswire4 months ago

    Digipath to Hold Conference Call to Review Results for the Fiscal Year Ended September 30, 2017

    LAS VEGAS, Jan. 8, 2018 /PRNewswire/ -- Digipath, Inc. (DIGP), a service-oriented independent testing laboratory and media firm focused on the developing cannabis market, will be holding a conference call to review its recently released results for the quarter and fiscal year ended September 30, 2017. The conference call will take place at 4:15pm Eastern Time on Tuesday, January 9, 2018. On the call from Digipath will be Mr. Joseph Bianco, CEO, Mr. Todd Denkin, COO/President, Dr. Cindy Orser, Chief Science Officer, and Mr. Todd Peterson, CFO.

  • Digipath Labs Awarded the Emerald Test Badge for Potency and Pesticides Testing
    PR Newswire4 months ago

    Digipath Labs Awarded the Emerald Test Badge for Potency and Pesticides Testing

    LAS VEGAS, Jan. 5, 2018 /PRNewswire/ -- Digipath, Inc. (DIGP) ("DIGP" or the "Company"), a service oriented independent testing laboratory and media firm focused on the developing cannabis market, today announced that Digipath Labs, its wholly owned subsidiary, has been awarded Emerald Test Badges for Potency and Pesticides Testing.  Emerald Test recognition demonstrates the lab's proficiency and commitment to a higher standard of excellence in Cannabis Testing.  The Emerald Test Badge results provide a measure of assurance and reliability to the industry as a whole, and particularly to those who depend on testing lab's results for safety, health, and product performance. The Emerald Test® uses the standard Inter-laboratory Comparison Proficiency Testing (ILC/PT) program for evaluating how accurately and dependably testing labs perform, by comparing how well the lab measures blinded samples. ILC/PT programs are common in many testing industries, including environmental, food, pharmaceutical, water and petrochemical, providing a point of reference on how well the testing labs are performing individually and as a group.  Individual labs can use their ILC/PT results to either verify proficiency to their customers and state regulatory bodies or to point out analytical tests needing further validation effort.

  • PR Newswire5 months ago

    Digipath, Inc. Announces Record Results for the Fiscal Year Ended September 30, 2017

    LAS VEGAS , Jan. 2, 2018 /PRNewswire/ -- Digipath, Inc. (OTCQB: DIGP) ("DIGP" or the "Company"), a service oriented independent testing laboratory and media firm focused on the developing ...

  • DigiPath, Inc. :DIGP-US: Earnings Analysis: Q3, 2017 By the Numbers : October 5, 2017
    Capital Cube7 months ago

    DigiPath, Inc. :DIGP-US: Earnings Analysis: Q3, 2017 By the Numbers : October 5, 2017

    Categories: Yahoo FinanceGet free summary analysis DigiPath, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of DigiPath, Inc. – Internet of Things Inc. (ITT-CA) that have also reported for this period. Highlights Summary numbers: Revenues of USD 0.39 million, Net Earnings of USD -0.41 million. ... Read more (Read more...)

  • PR Newswire8 months ago

    Digipath, Inc. Enters into Joint Venture to Establish a Cannabis Testing Laboratory in California

    LAS VEGAS, Sept. 25, 2017 /PRNewswire/ -- Digipath, Inc. (DIGP), an independent cannabis testing laboratory and media firm, is pleased to announce that it has entered into a joint venture with Mr. Don Ashley, an experienced real estate developer and cannabis entrepreneur, to establish and operate a cannabis testing laboratory in California. The joint venture, Humboldt Botanical, LLC, will conduct business under the name "Digipath Botanical Testing" and will launch Digipath's entry into the largest cannabis market in the United States. Pursuant to the joint venture agreement, Mr. Ashley will contribute up to $2 million to fund the build-out and equipping of the testing laboratory, while Digipath will be responsible for managing and supervising the day-to-day operations of the laboratory.  Digipath and Mr. Ashley will be entitled to receive 40% and 60%, respectively, of the joint venture's cash distributions, provided that until Mr. Ashley has received the return of his invested capital, distributions will made 75% to Mr. Ashley and 25% to Digipath.  Digipath has also provided the joint venture with a non-exclusive license to use its intellectual property in connection with the operation of the laboratory.

  • PR Newswire9 months ago

    Digipath, Inc. Announces Third Fiscal Quarter 2017 Results

    LAS VEGAS , Aug. 16, 2017 /PRNewswire/ -- Digipath, Inc. (OTCQB: DIGP) ("DIGP" or the "Company"), a service oriented independent testing laboratory and media firm focused on the developing ...

  • DigiPath, Inc. :DIGP-US: Earnings Analysis: Q2, 2017 By the Numbers : July 31, 2017
    Capital Cube10 months ago

    DigiPath, Inc. :DIGP-US: Earnings Analysis: Q2, 2017 By the Numbers : July 31, 2017

    Categories: Yahoo FinanceGet free summary analysis DigiPath, Inc. reports financial results for the quarter ended March 31, 2017. Highlights Summary numbers: Revenues of USD 0.50 million, Net Earnings of USD -0.22 million. Gross margins widened from -3.82% to 55.54% compared to the same period last year, operating (EBITDA) margins now -54.46% from -244.57%. Change in operating cash ... Read more (Read more...)

  • PR Newswire10 months ago

    Digipath Receives Recreational Testing License and Renews Medical License as Retail Cannabis Market Launches in Nevada

    LAS VEGAS, July 10, 2017 /PRNewswire/ -- Digipath, Inc. (DIGP), an independent testing laboratory and media firm focused on the burgeoning cannabis market, is pleased to announce that it has both received its recreational testing license and renewed its existing medical testing license alongside the launch of the highly anticipated retail cannabis market in Nevada which began on July 1, 2017. Nevada's medical cannabis market currently serves just over 28,000 patients that use the plant and its derivative products for the treatment of a variety of maladies.

  • PR Newswire11 months ago

    Digipath, Inc. to Present at the Southeast Cannabis Conference in Florida

    LAS VEGAS, June 7, 2017 /PRNewswire/ -- Digipath, Inc. (DIGP), an independent testing laboratory and media firm focused on the developing cannabis market, is pleased to announce that its President, Todd Denkin, will be a presenter at the Southeast Cannabis Conference on June 11, 2017, in Ft. Lauderdale, FL. Mr. Denkin will be presenting at the session entitled, "Cannabis Testing, Safety & Analytics," where he will be discussing the vital role that cannabis testing plays in the emerging cannabis marketplace, the value that testing and analytics provide to cannabis consumers, and the leadership role that Digipath has achieved in the market.